TME Pharma Case Study – Combination
Time: 2:00 pm
day: Pre-Conference Workshop Day
Details:
- Overview of the rationale behind exploring combination strategies at TME Pharma
- Importance of synergistic approaches in maximizing the effectiveness of myeloid cell interventions
- Exploration of various combination strategies involving myeloid cells, including Myeloid cell therapy combined with immunotherapies, combination with traditional cancer treatments (chemotherapy, radiation), integrating myeloid cell therapies with targeted therapies
- Exploration of emerging trends and innovative strategies in combining myeloid cell therapies
- Addressing regulatory considerations and challenges in translating combination therapies from bench to bedside
